Literature DB >> 27671227

Generation of Janus kinase 1 (JAK1) conditional knockout mice.

Kazuhito Sakamoto1, Barbara L Wehde1, Patrick D Rädler1, Aleata A Triplett1, Kay-Uwe Wagner1,2.   

Abstract

The biological functions of the Janus kinase 1 (JAK1) are suggested to be pleiotropic since this signal transducer is ubiquitously expressed and coupled to a variety of cytokine receptors. Consequently, mice that are deficient in this tyrosine kinase were reported to die shortly after birth. To facilitate studies that address the biological and molecular functions of JAK1 during postnatal development, we performed gene targeting in embryonic stem cells and generated a Cre/lox-based conditional knockout mouse model. Expression of Cre recombinase in the germline converted the Jak1 conditional knockout allele (Jak1fl ) into a null allele (Jak1- ) that when subsequently crossed into homozygosity led to a complete absence of the JAK1 protein in developing embryos. JAK1 deficient embryos were visibly smaller starting at E15.5. Newborn pups exhibited signs of apnea and died within hours after birth. The examination of fibroblasts from conditional knockout embryos and their littermate wildtype controls expressing JAK1 showed that lack of this Janus kinase resulted in an impaired tyrosine phosphorylation and activation of the downstream Signal Transducers and Activators of Transcription (STATs) 1, 3, and 6. JAK1 conditional knockout mice will be an invaluable tool to study cytokine signaling during normal development and disease progression in adult animals.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Cre recombinase; Janus kinase 1; STAT; embryonic development; gene targeting; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27671227     DOI: 10.1002/dvg.22982

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  8 in total

1.  Janus Kinase 1 Plays a Critical Role in Mammary Cancer Progression.

Authors:  Barbara L Wehde; Patrick D Rädler; Hridaya Shrestha; Stevi J Johnson; Aleata A Triplett; Kay-Uwe Wagner
Journal:  Cell Rep       Date:  2018-11-20       Impact factor: 9.423

Review 2.  Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells.

Authors:  Patrick D Rädler; Barbara L Wehde; Kay-Uwe Wagner
Journal:  Mol Cell Endocrinol       Date:  2017-05-08       Impact factor: 4.102

3.  Selective Janus kinase inhibition preserves interferon-λ-mediated antiviral responses.

Authors:  Daniel Schnepf; Stefania Crotta; Thiprampai Thamamongood; Megan Stanifer; Laura Polcik; Annette Ohnemus; Juliane Vier; Celia Jakob; Miriam Llorian; Hans Henrik Gad; Rune Hartmann; Birgit Strobl; Susanne Kirschnek; Steeve Boulant; Martin Schwemmle; Andreas Wack; Peter Staeheli
Journal:  Sci Immunol       Date:  2021-05-14

Review 4.  Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease.

Authors:  Friederike Cordes; Dirk Foell; John Nik Ding; Georg Varga; Dominik Bettenworth
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

5.  Genome Wide Analysis for Growth at Two Growth Stages in A New Fast-Growing Common Carp Strain (Cyprinus carpio L.).

Authors:  Shengyan Su; Bouzoualegh Raouf; Xinjin He; Nana Cai; Xinyuan Li; Juhua Yu; JianLin Li; Fan Yu; Meiyao Wang; Yongkai Tang
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

Review 6.  JAK/STAT Activation: A General Mechanism for Bone Development, Homeostasis, and Regeneration.

Authors:  Alexandra Damerau; Timo Gaber; Sarah Ohrndorf; Paula Hoff
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

7.  Dual recombinase action in the normal and neoplastic mammary gland epithelium.

Authors:  Patrick D Rädler; Kerry Vistisen; Aleata A Triplett; Rayane Dennaoui; Yong Li; Hridaya Shrestha; Rosa-Maria Ferraiuolo; Amalraj Thangasamy; Dieter Saur; Kay-Uwe Wagner
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

Review 8.  The JAK1/STAT3/SOCS3 axis in bone development, physiology, and pathology.

Authors:  Natalie A Sims
Journal:  Exp Mol Med       Date:  2020-08-13       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.